baber/WOPTO huggingface dataset:
Patent AU-2014301007-A1 (AU)
Title: Method for producing a multilayer element, and multilayer element
Inventor: BREHM LUDWIG
IPC: B42D25/00
Filed: 2014-06-26
Abstract: The invention relates to a method for producing a multilayer element (100, 200, 300, 400) and to a multilayer element (100, 200, 300, 400) produced using said method. A single-layer or multi-layer first décor layer (3) is applied to a carrier layer having a first side (11) and a second side (12). A metal layer (5) is applied to the side of the first décor layer (3) facing away from the carrier layer and is structured such that the metal layer (5) has a first thickness in one or more first zones (8) and a second thickness, different from the first thickness, in one or more second zones (9), wherein the second thickness is in particular equal to zero. A single-layer or multi-layer second décor layer (7) is applied to the side of the metal layer (5) facing away from the first décor layer (3), and using the metal layer (5) as a mask, is structured in such a manner that the first décor layer (3) and/or second décor layer (7) is at least partially removed in the first zones (8) or second zones (9).
Patent AU-2014347644-A1 (AU)
Title: Carboxymethyl piperidine derivative
Inventor: SHIMIZU KAZUO
IPC: C12N15/09
Filed: 2014-11-06
Abstract: The present invention provides a novel compound useful in the prevention or treatment of nausea and vomiting associated with the administration of antineoplastics, the compound having an NK
Patent AU-2014348713-A1 (AU)
Title: Water repellent, soil resistant, fluorine-free compositions
Inventor: BAUMANN MARKUS
IPC: D06M15/263
Filed: 2014-11-12
Abstract: The present invention pertains to a fluorine-free composition for treating textile articles being water repellant, sol resistant and stain resistant, especially carpets comprising a first composition comprising an aqueous silicone emulsion, an aqueous dispersion of a silane quaternary ammonium salt and water and a second composition comprising a soil repellency component that is an aqueous dispersion of colloidal organosiloxane copolymers.
Patent WO-2016061630-A1 (WO)
Title: Poteau de signalisation, système, procédé et kit
Inventor: BOLDEN RUSSELL JOHN
IPC: E01F9/011
Filed: 2015-10-23
Abstract: L'invention concerne un système d'étalonnage d'un poteau de signalisation, un procédé d'assemblage d'un poteau de signalisation et un kit comprenant un poteau de signalisation pour étalonnage. Selon un aspect, le système comprend : un support lisible par un ordinateur comprenant des instructions exécutables qui configurent un système de traitement pour : obtenir des données de localisation indicatives d'un premier emplacement et d'une pluralité de seconds emplacements sélectionnés par l'utilisateur ou associés à ce dernier ; et obtenir, sur base des données de localisation, des données d'étalonnage indicatives d'un déplacement angulaire entre le premier emplacement et chaque second emplacement ; et un kit pour assembler un poteau de signalisation comprenant un poteau et une pluralité d'éléments de signalisation pour chaque second emplacement s'étendant en sens radial à partir du poteau, une orientation radiale de chaque élément de signalisation étant réglable autour du poteau pour alignement avec le déplacement angulaire respectif indiqué par les données d'étalonnage pour le second emplacement respectif.
Patent AU-2015200991-A1 (AU)
Title: Laser rejuvenation
Inventor: FLETCHER ERICA
IPC: A61F9/008
Filed: 2015-02-26
Abstract: A method of treating a disease, disorder or condition of the eye includes irradiating the eye or eyes with a laser and subsequently detecting one or 5 more biological responses by the eye or eyes to thereby determine the effectiveness of the laser treatment. The one or more biological responses by the eye or eyes are responses by cells, tissues and/or molecules of the eye or eyes that indicate, are associated with, or are functionally linked to, the effectiveness of the laser treatment. This may include detecting or 10 measuring a change in the expression of one or more genes after laser treatment, such as cytoskeletal genes, matrix metalloproteinase genes, cell cycle genes and extracellular matrix genes. The method may include detecting or measuring cell differentiation, cell death and/or cell proliferation after laser treatment. Aft -~1000 (3 1800- I rn E - 700- 2 m 00t ~ l i t G _ mControl eye M Control eye 1.- M Lasered eye 2.- M Lasered eye n- = Fellow eye 1=1 Felloweye (OwD ~a 1.0-.C 0.0 o3- -10. -QC711 ApoEnull 8C57B16 ApoEnull
Patent AU-2015203668-A1 (AU)
Title: Flashback blood collection needle
Inventor: SIM TIONG YEE
IPC: A61B5/153
Filed: 2015-06-30
Abstract: A needle assembly includes a transparent or translucent housing with a fluid inlet and outlet end, a flashback chamber, and a venting mechanism therebetween. The venting mechanism includes a blocking member to control the fluid flow in the venting mechanism so that it flows along the longest path through the vent. Substantially axially aligned inlet and outlet cannulas extend from the housing and communicate with the chamber. A salable sleeve covers the external end of the outlet cannula. Relative volumes of the cannulas, the chamber, and the sleeve are selected to provide rapid reliable flashback indicative of venous entry with an internal vent positioned within the housing to divide the interior into first and second chambers, with the second chamber being adapted to maintain a negative pressure therein relative to the external environment so as to inhibit leakage of blood from the needle tip on withdrawal from the patient.
Patent AU-2015203851-A1 (AU)
Title: Process for producing aqueous chlorous acid solution for use as disinfectant
Inventor: GODA HISATAKA
IPC: A01N59/08
Filed: 2015-07-09
Abstract: A process for producing an aqueous chlorous acid solution, comprising the steps of: adding to a chlorous acid-containing solution at least one compound selected from the group consisting of inorganic and organic acids and salts or a combination thereof, to provide long-term stabilization of said chlorous acid for delaying the conversion of chlorous acid to chlorine dioxide and produce the aqueous chlorous acid solution in a form that is capable of sustaining chlorous acid for an extended time, wherein the pH of the aqueous chlorous acid solution is in the range of 3.2 to 8.0. Fig. 17 pH Fig.1 7 The time-course changes in pH values of the aqueous chlorous acid solutions and conbentional ASC solution -- SampleA --- SampleB 4.5 -&-- Samplec 4 -x-- SampleD 0 5 10 15 20 25 30 Day
Patent AU-2015218587-A1 (AU)
Title: Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
Inventor: WYNN THOMAS ANDREW
IPC: C07C311/04
Filed: 2015-02-24
Abstract: The present invention provides compounds and pharmaceutical compositions for treating neurological diseases such as multiple sclerosis.
Patent AU-2015242493-A1 (AU)
Title: Method for culturing microalgae of the Aurantiochytrium genus in a culture medium without chloride and without sodium, for the production of DHA
Inventor: CALLEJA PIERRE
IPC: C12N1/12
Filed: 2015-04-03
Abstract: The invention relates to a method for culturing a protist of the
Patent AU-2015243625-A1 (AU)
Title: Use of substituted oxo tetrahydroquinoline sulfonamides or salts thereof for raising stress tolerance of plants
Inventor: FRACKENPOHL JENS
IPC: A01P15/00
Filed: 2015-04-07
Abstract: The invention relates to the use of substituted oxo tetrahydroquinoline sulfonamides or salts thereof, wherein the groups in general formula (I) are defined as cited in the description, for raising the stress tolerance of plants with respect to abiotic stress and/or for increasing the plant yield.
Patent AU-2015246086-A1 (AU)
Title: System and method for user authentication by using a physical financial card and mobile communication
Inventor: SONG SUNG UN
IPC: G06Q20/14
Filed: 2015-10-08
Abstract: Provided are a user authentication system and method using a physical financial card. A user of the physical financial card is authenticated based on 5 information acquired from the physical financial card using a contact or non-contact scheme. When a user requesting authentication for the first time is successfully authenticated, a unique identifier (UID) of the physical financial card and a personal identification number (PIN) for the authentication are registered. The user is authenticated using the registered UID and PIN information in the next 10 authentication, so that security and convenience are improved.
Patent AU-2015252066-A1 (AU)
Title: Tilt mechanism for a window blind
Inventor: FRASER DONALD E
IPC: E06B9/307
Filed: 2015-11-04
Abstract: A blind (10*) is arranged such that minimal force is required to rotate the tilt drum (27*) to tilt the slats (12*) from the fully open to the fully closed position and back, with each of the front (14*) and rear (16*) tilt cables sharing the load nearly equally throughout the entire path from the fully open to the fully closed position and back. 37 28* d 10* 50* 52* 16* 14* -18* 12* 54* 56* FI 20*
Patent AU-2015255158-A1 (AU)
Title: Urine markers for detection of bladder cancer
Inventor: GUILFORD PARRY JOHN
IPC: C12N5/071
Filed: 2015-11-09
Abstract: This invention relates to detection of cancer. Specifically, this invention relates to the use of markers for the detection of bladder cancer. More specifically, this invention relates to use of urine markers for the detection of bladder cancer. Yet more specifically, this invention relates to use of oligonucleotide, protein, and/or antibody markers in the urine for detection, typing and staging of bladder cancer.
Patent AU-2015255300-A1 (AU)
Title: Antibodies directed to dll4 and uses thereof
Inventor: BEDIAN VAHE
IPC: A61K39/395
Filed: 2015-11-13
Abstract: Abstract The invention relates to targeted binding agents against DLL4 and uses of such agents. More specifically, the invention relates to fully human monoclonal antibodies directed to DLL4. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of DLL4 and as diagnostics.
Patent AU-2015261684-A1 (AU)
Title: Light-emitting apparatuses for treating and/or diagnosing motor-related neurological conditions
Inventor: SAVAGE KENT W
IPC: A61N5/06
Filed: 2015-11-27
Abstract: -24 Light-emission apparatuses emit light that is tailored to address and/or diagnose at least one motor-related neurological condition. Blue-green light and green light are useful for treating motor-related neurological conditions or their symptoms. 5 Deep red light and near infrared radiation may facilitate the repair of retinal cells and/or neurons that may be responsible for motor-related neurological conditions. Amber, orange and red light enable the early diagnosis of motor-related neurological conditions.
Patent AU-2015280647-A1 (AU)
Title: Systems and methods for producing a hardwearing alloy material
Inventor: ZHU YUANJI
IPC: C22B3/00
Filed: 2015-05-04
Abstract: Described herein are systems and methods for producing a hardwearing or wear-resistant material. In one aspect, a first group of materials comprising zirconium dioxide (ZrO
Patent AU-2015287891-A1 (AU)
Title: Method for attaching pumps to electric motors
Inventor: MEZA HUMBERTO V
IPC: F04B53/22
Filed: 2015-07-08
Abstract: A pump features a motor, a pump head (PH) and a locking pin (LP) that are uniquely coupled together. The motor has a front end bell (FEB) with a FEB coupling portion configured with twist lock style (TLS) connections with locking portions, and an outer surface with a detent. Each locking portion engages a respective corresponding locking portion when the FEB coupling portion, and the PH coupling portion is twisted together in relation to one another about the longitudinal axis of the pump. Each locking stop abuts against a respective locking portion to stop the FEB coupling portion and the PH coupling portion from twisting together, so the detent and the threaded orifice are aligned to receive the LP, and the motor and pump head are locked together and cannot be pulled apart.
Patent AU-2015301071-A1 (AU)
Title: Interleukin-2/Interleukin-2 Receptor alpha fusion proteins and methods of use
Inventor: MALEK THOMAS
IPC: A61K38/00
Filed: 2015-08-05
Abstract: Various methods and compositions are provided which can be employed to modulate the immune system. Compositions include a fusion protein comprising: (a) a first polypeptide comprising Interleukin-2 (IL-2) or a functional variant or fragment thereof; and (b) a second polypeptide, fused in frame to the first polypeptide, wherein the second polypeptide comprises an extracellular domain of Interleukin-2 Receptor alpha (IL-2Rα ) or a functional variant or fragment thereof, and wherein the fusion protein has IL-2 activity. Various methods are provided for modulating the immune response in a subject comprising administering to a subject in need thereof a therapeutically effective amount of the IL-2/IL-2Rα fusion protein disclosed herein.
Patent AU-2015313285-A1 (AU)
Title: Beverage characteristic adjusting device and method
Inventor: KOHARA KENJI
IPC: B67D1/12
Filed: 2015-09-08
Abstract: A beverage characteristic adjusting device (10) imparts a flavor to beer supplied by a dispensing system (1). The beverage characteristic adjusting device (10) is provided with a beverage characteristic adjusting container (20) connected to a beverage passage (7) through which beer is transferred, so as to be communicated with the beverage passage (7), the beverage characteristic adjusting container (20) being capable of introducing a steeped material for imparting a flavor to the beer, and the flow rate of beer introduced to the beverage characteristic adjusting container (20) is adjusted by a beer supply device (21) and a gas supply device (22).
Patent AU-2015320003-A1 (AU)
Title: Iron (III) hydroxide complexes with activated glucose syrups and process for preparing same
Inventor: TSETI IOULIA
IPC: A61K31/7004
Filed: 2015-07-28
Abstract: The present invention generally relates to iron (III) carbohydrate complexes and to processes for the manufacture thereof. The product obtainable according to the method of the present invention may be safely used to the general population or animals in the therapy of iron deficiency. The process of the invention includes the steps of (i) providing an aqueous solution of glucose syrup having a certain dextrose equivalent (DE), (ii) adding one or more oxidizing bleaching agents, thereby obtaining the activated glucose syrup; (iii) converting said activated glucose syrup into a complex with iron (III) hydroxide; and (iv) obtaining a complex of iron (III) hydroxide and activated glucose syrup.
Patent AU-2015323433-A1 (AU)
Title: Multi parameter swimming pool fluid analysis and regulating method and device
Inventor: YIZHACK TAMIR
IPC: E04H4/16
Filed: 2015-09-21
Abstract: There may be provided a system comprising a spectroscopic device; wherein the spectroscopic device is configured to analyze a fluid of a pool.
Patent AU-2015323744-A1 (AU)
Title: A method for predicting responsiveness to a treatment with an EGFR inhibitor
Inventor: THIEBAUT RAPHAELE
IPC: C12Q1/68
Filed: 2015-09-25
Abstract: The present invention relates to a method for predicting whether a patient with a cancer is likely to respond to an epidermal growth factor receptor (EGFR) inhibitor, which method comprises determining the expression level of hsa-miR-31-5p (SEQ ID NO:2) miRNA in a sample of said patient. The invention also relates to kits for measuring the expression of hsa-miR-31-5p and at least one other parameter positively or negatively correlated to response to EGFR inhibitors. The invention also relates to therapeutic uses of an EGFR inhibitor in a patient predicted to respond to said EGFR inhibitor.
Patent AU-2015330141-A1 (AU)
Title: Spirodiamine derivatives as aldosterone synthase inhibitors
Inventor: AEBI JOHANNES
IPC: C07D487/10
Filed: 2015-10-05
Abstract: The invention provides compounds having the general formula (I) pharmaceutical compositions containing the compounds and a process for their preparation. The compounds act as aldosterone synthase inhibitors and are for use in the treatment or prevention of chronic kidney disease, congestive heart failure, hypertension, primary aldosteronism and Cushing syndrom.
Patent AU-2015333923-A1 (AU)
Title: COPI coatomer beta subunit nucleic acid molecules that confer resistance to coleopteran and hemipteran pests
Inventor: NARVA KENNETH
IPC: C12N15/113
Filed: 2015-10-07
Abstract: This disclosure concerns nucleic acid molecules and methods of use thereof for control of insect pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in insect pests, including coleopteran and/or hemipteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of insect pests, and the plant cells and plants obtained thereby.
Patent AU-2015366355-A1 (AU)
Title: Drug delivery system for delivery of acid sensitive drugs
Inventor: MIHOV GEORGE
IPC: A61K9/70
Filed: 2015-12-18
Abstract: The present invention relates to a drug delivery system comprising a core and a shell in which the core comprises a hydrolytically degradable polymer X which polymer backbone comprises pendant ester and acid functionalities and in which the shell comprises a hydrolytic degradable polymer Y. The hydrolytic degradable polymers X and Y are different polymers. Polymer X further comprises amino-acids in the polymer backbone and degrades via zero order degradation kinetics for a period of at least 3 months. Polymer Y degrades via auto-acceleration degradation kinetics.
Patent WO-2016141424-A1 (WO)
Title: Moyen de support
Inventor: MURPHY LUKE ANTHONY
IPC: A47G1/16
Filed: 2016-03-05
Abstract: La présente invention concerne un support destiné à être installé dans ou sur un élément vertical, le support comportant une première région et une deuxième région, les première et deuxième régions étant séparées par un coude dans le support, la deuxième région ayant une région de fixation d'article. Le présent support peut être utilisé pour supporter un article tel qu'une étagère, ou pour suspendre un article en provenance de celui-ci. Le support de la présente invention est configuré de manière à pouvoir être inséré dans une rainure dans un élément vertical (tel qu'un mur) ou dans un moyen de réception qui est à son tour fixé ou inséré dans un élément vertical. L'invention concerne également un système de support comportant un support tel que décrit dans l'invention, et un élément sensiblement vertical comportant une rainure s'étendant dans celui-ci, la rainure étant inclinée dans l'élément et comportant une paroi supérieure et une paroi inférieure, éventuellement la paroi supérieure présentant un évidement disposé dans celui-ci. La rainure peut être inclinée vers le bas dans l'élément.
Patent AU-2016201145-A1 (AU)
Title: Organic composition for use with plants
Inventor: NUGENT MICHAEL R
IPC: C05F5/00
Filed: 2016-02-24
Abstract: An organic composition for use with plants is presented. The organic composition is a mixture of filtration waste with or without sand and further includes optional constituents such soil(s) and/or compostable material(s) and/or non-compostable material(s). The filtration waste further includes carbon, diatomaceous earth, and sugar. In some embodiments, the filtration waste is a byproduct from the refinement of sugar. In other embodiments, the filtration waste may be prepared by combining sugar, diatomaceous earth, and carbon. In yet other embodiments, the organic composition is prepared by removing the filtration waste from filtering equipment after the refinement of sugar and mixing the filtration waste with soil(s), compostable material(s), and/or non-compostable material(s). The organic composition is suitable for use as a growth medium for plants, a soil amendment, a soil additive, or a soil supplement.
Patent AU-2016203142-A1 (AU)
Title: A method of treating mucus hypersecretion
Inventor: O'HEHIR ROBYN
IPC: A61K31/711
Filed: 2016-05-13
Abstract: The present invention relates generally to a method of reducing unwanted airway tissue mucus secretion in a mammal and to agents useful for same. More particularly, the present invention relates to a method of reducing airway tissue mucus hypersecretion in a mammal by downregulating the functional level of activin or upregulating the functional level of follistatin. The method of the present invention is useful, inter alia, in the treatment and/or prophylaxis of conditions characterised by airway tissue mucus dysfunction, such as overproduction of mucus or decreased mucus clearance, and where a reduction in mucus secretion levels would thereby alleviate the condition.
Patent AU-2016206340-A1 (AU)
Title: Covering module
Inventor: PACIONE JOSEPH ROCCO
IPC: F16B5/07
Filed: 2016-07-21
Abstract: A covering module for installation on a subsurface and for attachment to additional modules to form a finished decorative surface is provided. The covering module comprises a decorative covering that is detachably or permanently attached to an anchor sheet. The covering module is configured so as to expose a joining region of the decorative covering and a joining region of the anchor sheet. WO 2010/105362 PCT/CA20 10/00040! Jo PT\4 ----------- r
Patent AU-2016219708-A1 (AU)
Title: Immune response inducer
Inventor: ISHIBASHI MASAKI
IPC: A61P43/00
Filed: 2016-08-26
Abstract: An immunity-inducing agent comprising as an effective ingredient a specific polypeptide is disclosed. These polypeptides were isolated, by the SEREX method 5 using a cDNA library derived from canine testis and serum from a cancer-bearing dog, as a polypeptide which binds to an antibody existing specifically in serum derived from a cancer-bearing living body. The polypeptides can induce immunity in a living body and cause regression of a tumor in a cancer-bearing living body. Therefore, these polypeptides are especially effective as a therapeutic and/or 10 prophylactic agent for a cancer(s).
Patent AU-2016240373-A1 (AU)
Title: Tools for calibrating an ultrasonic testing device
Inventor: NOEL ALEXANDRE
IPC: G01N29/48
Filed: 2016-03-25
Abstract: Module for assisting with the calibration of a device for testing metallurgical products comprising memory capable of storing data in the form of value/angle pairs. Each pair corresponds to an amplitude of response to an ultrasonic inspection in a direction of the metallurgical product corresponding to said angle. A computer is capable of executing a function for processing the stored data. A first set of data relates to a polydirectional reflector embedded in the metallurgical product. The pairs of the first set correspond to amplitudes of response to ultrasonic inspections in certain at least of the working directions of the polydirectional reflector. A second set of data relates to a directional reflector embedded in the metallurgical product. The second set of data comprises, for the directional reflector, at least one pair corresponding to an amplitude of response to an ultrasonic inspection in a working direction of the reflector. The processing function establishes a third set of data by interpolation of the pairs of the first set of data and of the second set of data. The pairs of the third set correspond to standard amplitudes for ultrasonic inspections in certain at least of the working directions of the polydirectional reflector.